Related Experiment Video
Updated: Jul 13, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
[Effect of vaccination against pneumococcal infection and influenza in children with asthma]
Insights
Pneumococcal and influenza vaccines reduced asthma exacerbations in children. Immunization increased IgG levels without raising IgE, indicating safety and efficacy in managing childhood asthma.
Area of Science:
- Pediatric Allergy and Immunology
- Vaccinology
- Respiratory Medicine
Background:
- Asthma exacerbations significantly impact children's quality of life.
- Pneumococcal and influenza infections can trigger asthma exacerbations.
- The role of vaccination in managing pediatric asthma requires further investigation.
Purpose of the Study:
- To assess the clinical course of asthma in children following immunization.
- To evaluate the IgG response to pneumococcal vaccination in children with asthma.
- To determine if combined pneumococcal and influenza vaccination impacts asthma exacerbations.
Main Methods:
- A study involving 78 children (aged 4-17) with asthma.
- Two groups were formed: one received pneumococcal and influenza vaccines, the other only pneumococcal vaccine.
- Clinical course (asthma exacerbations) and IgG levels were monitored post-vaccination.
Main Results:
- Asthma exacerbations decreased by 1.7 times in the combined vaccine group and 1.5 times in the pneumococcal-only group.
- Increased IgG levels to pneumococcal antigens were observed in both vaccinated groups.
- No significant increase in IgE levels was detected, suggesting no allergic sensitization.
Conclusions:
- Immunization against pneumococcal infection, alone or combined with influenza, reduces asthma exacerbations in children.
- Vaccination leads to protective immunity against Streptococcus pneumoniae without causing sensitization.
- Pneumococcal and influenza vaccines are safe and effective adjuncts in managing pediatric asthma.
Abstract:
Assessment of clinical course of asthma and IgG response in children with asthma immunized with pneumococcal polysaccharide vaccine (Pneumo 23) and influenza vaccine (Vaxigrip). 78 children aged 4 - 17 years old were allocated to two groups. Children from the 1st group were immunized against pneumococcal infection and influenza; children from 2nd group were immunized against pneumococcal infection only. Rate of asthma exacerbations in the 1st group of children decreased by 1.7 times compared with the period before vaccination, whereas the same rate in the 2nd group of children decreased by 1.5 times. It was accompanied by the increase of IgG level to antigens of pneumococcalvaccine in blood, which was observed in both groups. Vaccination did not result in increase of IgE levels. Immunization of children with asthma against pneumococcal infection with polysaccharide vaccine or combined immunization against pneumococcal infection and influenza reduced rate of asthma exacerbations and led to formation of immunity to vaccine strains of Streptococcus pneumoniae. Vaccination did not lead to sensitization of children.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Asthma I: Introduction
Vaccinations
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations